SCHEMBL23905698

SCHEMBL23905698

Cn1c(N)c(C(N)=O)c2nc(C3(C(F)(F)F)CC3)cnc21

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PKMYT1 Q99640 8/20 0.37
CYP2C9 P11712 3/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 1/20 0.34
BTK Q06187 1/20 0.33
EPHB4 P54760 2/20 0.31
PIK3CA P42336 1/20 0.30
WEE1 P30291 1/20 0.30
MYT1 Q01538 1/20 0.30
PDE1A P54750 1/20 0.30
PDE1B Q01064 1/20 0.30
PDE4D Q08499 1/20 0.30
PDE1C Q14123 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24708056 0.81 PDE1A (0.30) PDE1APDE1BPDE4DPDE1C
SCHEMBL23888225 0.78 PKMYT1 (0.70) PKMYT1CYP2C9CYP3A4CYP2D6WEE1
SCHEMBL29869281 0.78 PKMYT1 (0.70) PKMYT1CYP2C9CYP3A4CYP2D6WEE1
SCHEMBL23903101 0.77 PKMYT1 (0.47) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL23903403 0.77 PKMYT1 (0.38) PKMYT1CYP2C9CYP3A4CYP2D6BTK
SCHEMBL23903694 0.77 PKMYT1 (0.38) PKMYT1CYP2C9CYP3A4CYP2D6BTK
SCHEMBL23888285 0.76 PKMYT1 (0.58) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL29869642 0.76 PKMYT1 (0.58) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL23903669 0.73 PKMYT1 (0.60) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4
SCHEMBL23903337 0.72 PKMYT1 (0.37) PKMYT1CYP2C9CYP3A4CYP2D6EPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022213204-A1 COMBINATION THERAPIES INCLUDING MYT1 INHIBITORS REPARE THERAPEUTICS INC. (CA) 2022-10-13 WO disclosed
WO-2021195782-A1 METHODS OF USING MYT1 INHIBITORS REPARE THERAPEUTICS INC. (CA) 2021-10-07 WO disclosed